SYDNEY, AUSTRALIA — Cochlear has reached a new milestone in the development of its fully implantable hearing technology, with patients across the company’s research programs now accumulating more than 1 million hours of experience with investigational devices....
Continue reading at Hearing Health Matters
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a research milestone announcement for an investigational device not yet approved for clinical use; audiologists cannot prescribe or recommend fully implantable Cochlear devices at this time.
Reaching one million patient-hours of real-world experience with fully implantable hearing technology signals meaningful progress toward eventual regulatory submission, which could reshape candidacy counseling and surgical audiology practice in the coming years.
- 01Cochlear reports >1 million cumulative patient-hours with investigational fully implantable hearing devices.
- 02The technology remains in research/investigational status and is not commercially available.
- 03The milestone is framed as a development and safety data-accumulation marker, not a regulatory approval.
- 04Fully implantable devices eliminate all external components, a key differentiator from current hearing aids and cochlear implants.
- 05No peer-reviewed outcome data or efficacy results were published alongside this announcement.
Patients in Cochlear's research programs have accumulated over 1 million hours of experience with investigational fully implantable hearing devices.
press releaseunclearAccumulating 1 million patient-hours represents a meaningful development milestone for fully implantable hearing technology.
press releasepromotional